SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-010798
Filing Date
2015-11-16
Accepted
2015-11-16 16:01:06
Documents
14
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ceru-10q_20150930.htm 10-Q 1594861
2 EX-10.1 ceru-ex101_151.htm EX-10.1 71500
3 EX-10.2 ceru-ex102_152.htm EX-10.2 72457
4 EX-10.3 ceru-ex103_153.htm EX-10.3 86351
5 EX-31.1 ceru-ex311_8.htm EX-31.1 13676
6 EX-31.2 ceru-ex312_10.htm EX-31.2 13636
7 EX-32.1 ceru-ex321_12.htm EX-32.1 4469
8 EX-32.2 ceru-ex322_7.htm EX-32.2 4420
  Complete submission text file 0001564590-15-010798.txt   4337383

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ceru-20150930.xml EX-101.INS 591121
10 XBRL TAXONOMY EXTENSION SCHEMA ceru-20150930.xsd EX-101.SCH 29501
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ceru-20150930_cal.xml EX-101.CAL 29859
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ceru-20150930_def.xml EX-101.DEF 104116
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ceru-20150930_lab.xml EX-101.LAB 268552
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ceru-20150930_pre.xml EX-101.PRE 201031
Mailing Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139
Business Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139 617-551-9600
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 151234198
SIC: 2834 Pharmaceutical Preparations